In another move by US academia to cuts its ties with commerce, the Johns Hopkins University Medicine School (JHM) has adopted a new policy that significantly limits interactions with industry while ensuring effective, principled and appropriate partnerships with pharmaceutical and medical device makers. Earlier this month, similar action was advocated by a group of physicians writing in the Journal of the American Medical Association (Marketletter April 13).
Called the Johns Hopkins Medicine Policy on Interaction with Industry, the policy will take effect July 1. Chief among the new rules are those that prohibit the acceptance of gifts or entertainment - including food - regardless of value, from drug and device companies. Consulting arrangements that carry personal compensation but no real duties also are prohibited and, beginning in 2010, the JHM will no longer accept free medicine samples, although in some limited cases, those that are de-identified (ie, without the brand or manufacturer's name), may be used for patient education.
Restricts medical reps access
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze